SLE Conundrums.
Wardle
E Nigel
EN
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D015551:Autoimmunity / Q000235:genetics; D053264:B-Cell Activating Factor / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D019175:DNA Methylation; D020022:Genetic Predisposition to Disease; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D000069283:Rituximab; D016896:Treatment Outcome; D049951:X Chromosome Inactivation
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D053264:B-Cell Activating Factor; D007155:Immunologic Factors; C505719:TNFSF13B protein, human; D000069283:Rituximab